Jan MM. Misdiagnosis in children with dopa-responsive dystonia. Pediatr Neurol. 2004;31:298-303.
Fernández-Alvarez E. Prevalence of paediatric movement disorders. In: Fernández-Alvarez E, Arzimanoglou A, Tolosa E, eds. Paediatric movement disorders. Montrouge, France: John Libbey Eurotext; 2005:1-18.
Jankovich J, Penn AS. Severe dystonia and myoglobinuria. Neurology. 1982;32:1195-1197.
Pierro MM, Bollea L, Di Rosa G, et al. Anoxic brain injury following near-drowning in children. Rehabilitation outcome: three case reports. Brain Inj. 2005;19:1147-1155.
Sanger TD. Toward a definition of childhood dystonia. Curr Opin Pediatr. 2004;16:623-627.
Fernández-Alvarez E. Dystonia. The paediatric perspective. Eur J Neurol. 2010;17(suppl 1):46-51.
Sanger TD, Chen D, Fehlings DL, et al. Definition and classification of hyperkinetic movements in childhood. Mov Disord. 2010;25;1538-1549.
Albanese A, Barnes MP, Bhatia KP, et al. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol. 2006;13:433-444.
Assmann B, Surtees R, Hoffmann GF. Approach to the diagnosis of neurotransmitter diseases exemplified by the differential diagnosis of childhood-onset dystonia. Ann Neurol. 2003;54(Suppl 6):S18-S24.
Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol. 1995;38:571-579.
Silver K, Andermannn F. Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment. Neurology. 1993;43:36-41.
Shapiro SM, Bhutani VK, Johnson L. Hyperbilirubinemia and kernicterus. Clin Perinatol. 2006;33:387-410.
Jinnah HA, Visser JE, Harris JC, et al. Delineation of the motor disorder of Lesch-Nyhan disease. Brain. 2006;129:1201-1217.
Jinnah HA, Harris JC, Nyhan WL. The spectrum of mutations causing HPRT deficiency: an update. Nucleosides Nucleotides Nucleic Acids. 2004;23:1153-1160.
Carrozzo R, Piemonte F, Tessa A, et al. Infantile mitochondrial disorders. Biosci Rep. 2007;27:105-112.
Gordon N. Pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome). Eur J Paediatr Neurol. 2002;6:243-247.
Goutieres F. Aicardi-Goutieres syndrome. Brain Dev. 2005;27:201-206.
Fenichel GM. Paroxysmal disorders. In: Fenichel GM, ed. Clinical pediatric neurology - a signs and symptoms approach. Philadelphia, PA: Elsevier Saunders; 2005:1-45.
1. Fahn S, Bressman SB, Marsden CD. Classification of dystonia. Adv Neurol. 1998;78:1-10.
2. Geyer HL, Bressman SB. The diagnosis of dystonia. Lancet Neurol. 2006;5:780-790.
3. Obese JA. General concepts. In: Fernández-Alvarez E, Aicardi J, eds. Movement disorders in children. London: Mac Keith Press; 2001:1-23.
4. Kamal N, Bhat DP, Carrick E. Dopa-responsive dystonia (Segawa syndrome). Indian Pediatr. 2006;43:635-638.
5. Jan MM. Misdiagnosis in children with dopa-responsive dystonia. Pediatr Neurol. 2004;31:298-303.
6. Mink JW. Functional anatomy of the basal ganglia. In: Stacy MA, ed. Handbook of dystonia. New York, NY: Informa Healthcare; 2007:45-56.
7. Ozelius L, Kramer PL, Moskowitz CB, et al. Human gene torsin dystonia located on chromosome 9q32-q34. Neuron. 1989;2:1427-1434.
8. Rostasy K, Augood SJ, Hewett JW, et al. TorsinA protein and neuropathology in early onset generalized dystonia with GAC deletion. Neurobiol Dis. 2003;12:11-24.
9. Siegert S, Bahn E, Kramer ML, et al. TorsinA expression is detectable in human infants as young as 4 weeks old. Brain Res Dev Brain Res. 2005;157:19-26.
10. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet. 1994;8:236-242.
11. Ludecke B, Dworniczak B, Bartholome K. A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum Genet. 1995;95:123-125.
12. Suls A, Dedeken P, Goffin K, et al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain. 2008;131:1831-1844.
13. Kurian MA, Zhen J, Cheng S-Y, et al. Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J Clin Invest. 2009;119:1595-1603.
14. Asmus F, Langseth A, Doherty E, et al. "Jerky" dystonia in children: spectrum of phenotypes and genetic testing. Mov Disord. 2009;24:702-709.
15. Heinzen EL, Swoboda KJ, Hitomi Y, et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet. 2012;44:1030-1034.
16. Brashear A, Mink JW, Hill DF, et al. ATP1A3 mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia. Dev Med Child Neurol. 2012;54:1065-1067.
17. Wang JL, Cao L, Li XH, et al. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain. 2011;134:3493-3501.
18. Fernández-Alvarez E. Prevalence of paediatric movement disorders. In: Fernández-Alvarez E, Arzimanoglou A, Tolosa E, eds. Paediatric movement disorders. Montrouge, France: John Libbey Eurotext; 2005:1-18.
19. Funk CB, Prasad AN, Frosk P, et al. Neuropathological, biochemical and molecular findings in a glutaric academia type 1 cohort. Brain. 2005;128(Pt 4):711-722.
20. Tanji K, Kunimatsu T, Vu TH, et al. Neuropathological features of mitochondrial disorders. Semin Cell Dev Biol. 2001;12:429-439.
21. Nasrallah IM, Minarcik JC, Golden JA. A polyalanine tract expansion in Arx forms intranuclear inclusions and results in increased cell death. J Cell Biol. 2004;167:411-416.
22. Guerrini R, Moro F, Kato M, et al. Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus. Neurology. 2007;69:427-433.
23. Hanko E, Hansen TW, Almaas R, et al. Bilirubin induces apoptosis and necrosis in human NT2-N neurons. Pediatr Res. 2005;57:179-184.
24. Bredenkamp JK, Maceri DR. Inflammatory torticollis in children. Arch Otolaryngol Head Neck Surg. 1990;116:310-313.
25. Dressler D, Benecke R. Diagnosis and management of acute movement disorders. J Neurol. 2005;252:1299-1306.
26. Bergman I, Steeves M, Burckart G, et al. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. J Pediatr 1991;119:644-649.
27. Beltran RS, Coker SB. Transient dystonia of infancy, a result of intrauterine cocaine exposure? Pediatr Neurol. 1995;12:354-356.
28. Gokhale SG, Panchakshari MB. Maternal medication causing drug dystonia in a newborn: placental transfer of drugs. J Matern Fetal Neonatal Med. 2004;16:215-217.
29. Shafrir Y, Levy Y, Beharab A, et al. Acute dystonic reaction to bethanechol - a direct acetylcholine receptor agonist. Dev Med Child Neurol. 1986;28:646-648.
30. Howrie DL, Rowley AH, Krenzelok EP. Benztropine-induced acute dystonic reaction. Ann Emerg Med. 1986;15:594-596.
31. Shafrir Y, Levy Y, Steinherz R. Acute dystonic reaction due to domperidone in an infant [in Hebrew]. Harefuah. 1986;110:237-238.
32. Hibbs AM, Lorch SA. Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review. Pediatrics. 2006;118:746-752.
33. Meija NI, Jankovic J. Metoclopramide-induced tardive dyskinesia in an infant. Mov Disord. 2005;20:86-89.
34. Angelini L, Zorzi G, Rumi V, et al. Transient paroxysmal dystonia in an infant possibly induced by cisapride. Ital J Neurol Sci. 1996;17:157-159.
35. Kawana S, Toyoshima Y, Tobise F, et al. Dystonic reaction following general anesthesia in a 2-month-old infant. Paediatr Anaesth. 2007;17:901-902.
36. Crosley CJ, Swender PT. Dystonia associated with carbamazepine administration: experience in brain-damaged children. Pediatrics. 1979;63:612-615.
37. Adams SB Jr, Flynn JM, Hosalkar HS, et al. Torticollis in an infant caused by hereditary muscle aplasia. Am J Orthop. 2003;32:556-558.
38. Caress JB, Nohria V, Fuchs H, et al. Torticollis acquired in late infancy due to a cerebellar gangliocytoma. Int J Pediatr Otorhinolaryngol. 1996;36:39-44.
39. Ekinci S, Karnak I, Tanyel FC. Infantile fibromatosis of the sternocleidomastoid muscle mimicking muscular torticollis. J Pediatr Surg. 2004;39:1424-1425.
40. Lehwald N, Krausch M, Franke C, et al. Sandifer syndrome - a multidisciplinary diagnostic and therapeutic challenge. Eur J Pediatr Surg. 2007;17:203-206.
41. Dimaala J, Chaljub G, Oto A, et al. Odontoid osteomyelitis masquerading as a C2 fracture in an 18-month-old male with torticollis: CT and MRI features. Emerg Radiol. 2006;12:234-236.
42. Mukherjee S, Sharief N. Bacterial meningitis presenting as acute torticollis. Acta Paediatr. 2004;93:1005-1006.
43. Kiblinger GD, Wallace BS, Hines M, et al. Spasmus nutans-like nystagmus is often associated with underlying ocular, intracranial, or systemic abnormalities. J Neuro-ophthalmol. 2007;27:118-122.
44. Nordli DR Jr, Kuroda MM, Hirsch LJ. The ontogeny of partial seizures in infants and young children. Epilepsia. 2001;42:986-990.
45. Cataltepe SU, Barron TF. Benign paroxysmal torticollis presenting as "seizures" in infancy. Clin Pediatr (Phila). 1993;32:564-565.
46. Jankovich J, Penn AS. Severe dystonia and myoglobinuria. Neurology. 1982;32:1195-1197.
47. Pierro MM, Bollea L, Di Rosa G, et al. Anoxic brain injury following near-drowning in children. Rehabilitation outcome: three case reports. Brain Inj. 2005;19:1147-1155.
48. Mariotti P, Fasano A, Contarino MF, et al. Management of status dystonicus: our experience and review of the literature. Mov Disord. 2007;22:963-968.
49. Teive HA, Munhoz RP, Souza MM, et al. Status dystonicus: study of five cases. Arq Neuropsiquiatr. 2005;63:26-29.
50. Manji H, Howard RS, Miller DH, et al. Status dystonicus: the syndrome and its management. Brain. 1998;121(Pt 2):243-252.
51. Horster F, Hoffmann GF. Pathophysiology, diagnosis, and treatment of methylmalonic aciduria - recent advances and new challenges. Pediatr Nephrol. 2004;19:1071-1074.
52. Jimenez Caballero PE, Marsal Alanso C. Type 1 glutaric aciduria: clinical and therapeutic implications. Neurologia. 2007;22:329-332.
53. Martínez Granero MA, Garcia Pérez A, Martínez-Pardo M, et al. Macrocephaly the first manifestation of glutaric aciduria type I: the importance of early diagnosis [in Spanish]. Neurologia. 2005;20:255-260.
54. Zhou L, Chillag KL, Nigro MA. Hyperekplexia: a treatable neurogenetic disease. Brain Dev. 2002;24:669-674.
55. Sanger TD. Toward a definition of childhood dystonia. Curr Opin Pediatr. 2004;16:623-627.
56. Fernández-Alvarez E. Dystonia. The paediatric perspective. Eur J Neurol. 2010;17(suppl 1):46-51.
57. Sanger TD, Chen D, Fehlings DL, et al. Definition and classification of hyperkinetic movements in childhood. Mov Disord. 2010;25;1538-1549.
58. Albanese A, Barnes MP, Bhatia KP, et al. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol. 2006;13:433-444.
59. Giffin N, Benton S, Goadsby PS. Benign paroxysmal torticollis of infancy; four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol. 2002;44:490-493.
60. Assmann B, Surtees R, Hoffmann GF. Approach to the diagnosis of neurotransmitter diseases exemplified by the differential diagnosis of childhood-onset dystonia. Ann Neurol. 2003;54(Suppl 6):S18-S24.
61. Willemse J. Benign idiopathic dystonia with onset in the first year of life. Dev Med Child Neurol. 1986;28:355-360.
62. Deonna TW, Ziegler AL, Nielsen J. Transient idiopathic dystonia in infancy. Neuropediatrics. 1991;22:220-224.
63. Deonna T, Martin D. Benign paroxysmal torticollis in infancy. Arch Dis Child. 1981;56:956-959.
64. Dunn DW, Snyder CH. Benign paroxysmal vertigo of childhood. Am J Dis Child. 1976;130:1099-1100.
65. Do TT. Congenital muscular torticollis: current concepts and review of treatment. Curr Opin Pediatr. 2006;1881:26-29.
66. de Chalain TM, Park S. Torticollis associated with positional plagiocephaly: a growing epidemic. J Craniofac Surg. 2005;16:411-418.
67. Tien YC, Su JY, Lin GT, et al. Ultrasonographic study of the coexistence of muscular torticollis and dysplasia of the hip. J Pediatr Orthop. 2001;21:343-347.
68. Snyder EM, Coley BD. Limited value of plain radiographs in infant torticollis. Pediatrics. 2006;118:e1779-e1784.
69. Parikh SN, Crawford AH, Choudhury S. Magnetic resonance imaging in evaluation of infantile torticollis. Orthopedics. 2004;27:509-515.
70. Lotze T, Jankovic J. Paroxysmal kinesigenic dyskinesias. Semin Pediatr Neurol. 2003;10:68-79.
71. Bennett LB, Roach ES, Bowcock AM. A locus for paroxysmal kinesigenic dyskinesia maps to human chromosome 16. Neurology. 2000;54:125-130.
72. Cuenca-Leon E, Cormand B, Thomson T, et al. Paroxysmal kinesigenic dyskinesia and generalized seizures: clinical and genetic analysis in a Spanish pedigree. Neuropediatrics. 2002;33:288-293.
73. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol. 1995;38:571-579.
74. Lee HY, Xu Y, Huang Y, et al. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet. 2004;13:3161-170.
75. Silver K, Andermannn F. Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment. Neurology. 1993;43:36-41.
76. Sweney MT, Silver K, Gerard-Blanluet M, et al. Alternating hemiplegia of childhood: early characteristics and evolution of a neurodevelopmental syndrome. Pediatrics. 2009;123:e534-e541.
77. Fraioli B, Guglielmi G, Baldassarre L. Clinical study of dantrolene sodium in the treatment of spastic and dystonic syndromes. Riv Neurol. 1976;46:333-350.
78. Nomura Y, Ikeuchi T, Tsuji S, et al. Two phenotypes and anticipation observed in Japanese cases with early onset torsion dystonia (DYT1) - pathophysiological consideration. Brain Dev. 2000;22(Suppl 1):S92-S101.
79. Burke RE, Fahn S, Gold AP. Delayed-onset dystonia in patients with "static" encephalopathy. J Neurol Neurosurg Psychiatry. 1980;43:789-797.
80. Bianca S, Bianca M. A new deletion in autosomal dominant guanosine triphosphate cyclohydrolase I deficiency gene - Segawa disease. J Neural Transm. 2006;113:159-162.
81. Brautigam C, Steenbergen-Spanjers GC, Hoffmann GF, et al. Biochemical and molecular genetic characteristics of the severe form of thyrosine hydroxylase deficiency. Clin Chem. 1999;45:2073-2078.
82. Hoffmann GF, Assmann B, Brautigam C, et al. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Ann Neurol. 2003;54(Suppl 6):S56-S65.
83. Diepold K, Schutz B, Rostasy K, et al. Levodopa-responsive infantile parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by viral infections. Mov Disord. 2005;20:764-767.
84. Lopez-Laso E, Camino R, Mateos ME, et al. Dopa-responsive infantile hypokinetic rigid syndrome due to dominant guanosine triphosphate cyclohydrolase 1 deficiency. J Neurol Sci. 2007;256:90-93.
85. Saint Hilaire MH, Burke RE, Bressman SB, et al. Delayed-onset dystonia due to perinatal or early childhood asphyxia. Neurology. 1991;41:216-222.
86. Hoon AH Jr, Reinhardt EM, Kelley RI, et al. Brain magnetic resonance imaging in suspected extrapyramidal cerebral palsy: observations in distinguishing genetic-metabolic from acquired causes. J Pediatr. 1997;131:240-245.
87. O'Suilleabhain P, Dewey RB Jr. Movement disorders after head injury: diagnosis and management. J Head Trauma Rehabil. 2004;19:305-313.
88. Alkhani A, Bohlega S. Unilateral pallidotomy for hemidystonia. Mov Disord. 2006;21:852-855.
89. Kostic VS, Covickovic-Sternic N, Svetel-Stojanovic M, et al. Delayed-onset dystonia due to asphyxia in the perinatal period [in Serbian]. Srp Arh Celok Lek. 1997;125:84-88.
90. Chuang C, Fahn S, Frucht SJ. The natural history and treatment of acquired hemidystonia: report of 33 cases and review of the literature. J Neurol Neurosurg Psychiatry. 2002;72:59-67.
91. Shapiro SM, Bhutani VK, Johnson L. Hyperbilirubinemia and kernicterus. Clin Perinatol. 2006;33:387-410.
92. Strauss KA, Puffenberger EG, Robinson DL, et al. Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet. 2003;121:38-52.
93. Kölker S, Christensen E, Leonard JV, et al. Diagnosis and management of glutaric aciduria type I - revised recommendations. J Inherit Metab Dis. 2011;34:677-694.
94. Jin H, Zou LP, Zhang CH, et al. Diagnosis and treatment of methylmalonic academia in 14 cases [in Chinese]. Zhonghua Er Ke Za Zi. 2004;42:581-584.
95. Jinnah HA, Visser JE, Harris JC, et al. Delineation of the motor disorder of Lesch-Nyhan disease. Brain. 2006;129:1201-1217.
96. Page T, Bakay B, Nissinen E. Hypoxanthine-guanine phosphoribosyltransferase variants: correlation of clinical phenotype with enzyme activity. J Inherit Metab Dis. 1981;4:203-206.
97. Jinnah HA, Harris JC, Nyhan WL. The spectrum of mutations causing HPRT deficiency: an update. Nucleosides Nucleotides Nucleic Acids. 2004;23:1153-1160.
98. Brismar J, Brismar G, Coates R, et al. Increased density of the thalamus on CT scans in patients with GM2 gangliosidoses. AJNR Am J Neuroradiol. 1990;11:125-130.
99. Yamada E, Matsumoto M, Hazaa F, et al. Two siblings, including a fetus, with Tay-Sachs disease. Acta Pathol (Jpn). 1981;31:1053-1061.
100. Carrozzo R, Piemonte F, Tessa A, et al. Infantile mitochondrial disorders. Biosci Rep. 2007;27:105-112.
101. Carrozzo R, Dionisi-Vici C, Steuerwald U, et al. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain. 2007;130:862-874.
102. McFarland R, Chinnery PF, Blakely EL, et al. Homoplasmy, heteroplasmy, and mitochondrial dystonia. Neurology. 2007;69:911-916.
103. Filosto M, Tomelleri G, Tonin P, et al. Neuropathology of mitochondrial diseases. Biosci Rep. 2007;27:23-30.
104. Hayflick SJ. Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name. Curr Opin Pediatr. 2003;15:572-577.
105. Rao C, Murthy V, Hedge R, et al. Hallervorden Spatz disease. Indian J Pediatr. 2003;70:513-514.
106. Ching KH, Westaway SK, Gitschier J, et al. HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration. Neurology. 2002;58:1673-1674.
107. Ostergaard JR, Christensen T, Hansen KN. In vivo diagnosis of Hallervorden-Spatz disease. Dev Med Child Neurol. 1995;37:827-833.
108. Gordon N. Pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome). Eur J Paediatr Neurol. 2002;6:243-247.
109. Matarin MM, Singleton AB, Houlden H. PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease. Neurosci Lett. 2006;407:162-165.
110. Wohlrab G, Uyanık G, Gross C, et al. Familial West syndrome and dystonia caused by Aristaless related homeobox gene mutation. Eur J Pediatr. 2005;164:326-328.
111. Stromme P, Mangelsdorf ME, Scheffer EI, et al. Infantile spasms, dystonia, and other X-linked phenotypes caused by mutations in Aristaless related homeobox gene, ARX. Brain Dev. 2002;24:266-268.
112. Rice G, Patrick T, Parmar R, et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet. 2007;81:713-725.
113. Grosso S, Lasorella G, Russo A, et al. Aicardi syndrome with favorable outcome: case report and review. Brain Dev. 2007;29:443-446.
114. Ostergaard JR, Christensen T. Aicardi-Goutieres syndrome: neuroradiological findings after nine years of follow-up. Eur J Paediatr Neurol. 2004;8:243-246.
115. Aicardi J, Goutieres F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol. 1984;15:49-54.
116. Goutieres F. Aicardi-Goutieres syndrome. Brain Dev. 2005;27:201-206.
117. Kabakus N, Kurt A. Sandifer syndrome: a continuing problem of misdiagnosis. Pediatr Int. 2006;48:622-625.
118. Smith DE, Fitzgerald K, Stass-Isern M, et al. Electroretinography is necessary for spasmus nutans diagnosis. Pediatr Neurol. 2000;23:33-36.
119. Vigevano F, Bartuli A. Infantile epileptic syndromes and metabolic etiologies. J Child Neurol. 2002;17(suppl 3):3S9-3S13.
120. Fenichel GM. Paroxysmal disorders. In: Fenichel GM, ed. Clinical pediatric neurology - a signs and symptoms approach. Philadelphia, PA: Elsevier Saunders; 2005:1-45.
121. Ouvrier R, Billson F. Paroxysmal tonic upgaze of childhood - a review. Brain Dev. 2005;27:185-188.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台